|
Market Closed -
Australian S.E.
02:10:26 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.2450 AUD | -2.00% |
|
-.--% | -27.94% |
| 10-08 | Paradigm Biopharmaceuticals Flags Missing Trial Data, Maintains Trading Suspension | MT |
| 10-08 | Paradigm Biopharmaceuticals Limited Provides Update on the Phase 3 Data | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.00% | -.--% | -.--% | +44.12% | -27.94% | -38.75% | -64.75% | -87.40% | -55.45% | 102M | |
| +1.52% | -7.16% | -8.44% | +24.27% | +61.63% | +51.66% | +67.41% | +1.95% | - | 65B | |
| +1.52% | +6.83% | +11.73% | +8.53% | +14.02% | +10.89% | +79.30% | -15.16% | +230.03% | 51.2B | |
| +0.30% | -0.46% | -15.92% | -3.16% | +1.81% | -0.03% | +61.89% | +184.97% | +4,878.17% | 51.19B | |
| -0.87% | +0.99% | -1.88% | +29.87% | +17.48% | +24.88% | +41.80% | +6.34% | +252.09% | 43.93B | |
| +0.72% | +6.02% | +1.59% | +19.62% | +22.28% | +16.61% | +134.13% | -1.20% | +1,031.57% | 41.96B | |
| +2.50% | -6.22% | -5.64% | +0.83% | +128.37% | +236.78% | +527.22% | +561.92% | - | 38.14B | |
| +2.16% | +10.36% | +10.48% | +12.74% | +14.98% | +18.92% | +59.70% | +11.35% | +163.60% | 33.24B | |
| -0.90% | -10.49% | -4.27% | +30.34% | +53.31% | +37.09% | +1.80% | -58.05% | - | 25.2B | |
| +1.60% | +2.21% | +12.48% | +37.63% | +25.41% | +27.96% | +28.00% | -12.65% | +122.01% | 22.5B | |
| +2.08% | -6.99% | -9.04% | -3.28% | -6.37% | -17.42% | -4.40% | -66.09% | - | 22.03B | |
| -0.73% | -2.84% | -20.86% | -10.52% | -44.98% | -42.97% | +279.55% | +259.46% | +602.57% | 21.02B | |
| +0.49% | +0.38% | -0.28% | +17.90% | +10.82% | +14.33% | +171.14% | +235.23% | +1,922.19% | 17.26B | |
| -5.62% | -1.67% | -0.42% | -1.67% | +177.32% | +152.60% | +374.24% | +1,427.38% | +748.34% | 15.9B | |
| +0.55% | +4.32% | +9.06% | +12.38% | +42.38% | +80.67% | +199.59% | +190.26% | +441.71% | 15.42B | |
| +0.87% | +1.65% | +1.13% | +11.03% | +26.51% | +23.54% | +66.26% | -29.05% | +86.95% | 15.28B | |
| +2.85% | +1.81% | -2.73% | -8.21% | - | - | - | - | - | 14.79B | |
| -0.20% | -0.76% | +7.36% | +36.35% | +50.17% | +62.68% | +59.85% | -27.38% | +271.75% | 14.33B | |
| +3.10% | +1.66% | -2.08% | -7.07% | +15.25% | -1.40% | +496.31% | - | - | 13.77B | |
| -1.28% | +1.95% | -1.15% | +0.85% | -8.02% | -11.06% | -25.69% | -39.62% | +113.64% | 13.13B | |
| Average | +0.41% | -0.00% | -0.94% | +12.63% | +30.23% | +34.05% | +134.39% | +141.24% | +772.08% | 26.77B | |
| Weighted average by Cap. | +0.72% | -0.25% | -1.76% | +12.55% | +33.86% | +39.66% | +130.55% | +121.21% | +1,108.92% |
- Stock Market
- Stocks
- PAR Stock
- Sector Paradigm Biopharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
